Neuropathological changes
The more severe cases of ADC are characterised pathologically by prominent microgranulomatous foci of multinucleate giant cells (MGC) that are initially found in the cerebral white matter and, as the disease progresses, these abnormalities are found more frequently in the grey matter.3 8 The occurrence of MGC is accompanied by reactive gliosis, a term for an increase in both the size and number of astrocytes and the infiltration by cells of the monocytoid lineage, the brain derived microglial cells, and blood derived macrophages3; this condition is referred to as HIV encephalitis. Vacuolar myelopathy can also be a common pathological observation in affected brain but is more frequently found in the spinal cord. 8 The earliest lesions of vacuolar myelopathy consist of intramyelin swelling causing vacuolation, while severe cases also show evidence of gross demyelination and axonal loss. These lesions are characterised by a minimal inflammatory response with macrophages only occasionally observed around sites of vacuolation. 5 The occurrence of vacuolar myelopathy is not predicted by the presence of HIV encephalitis as the two may occur independently, or concurrently, although MGC are found more frequently in patients with severe vacuolar myelopathy.9 There is a third pathological condition identified by diffuse damage to the cerebral and cerebellar white matter that creates a general white matter pallor and has the characteristic traits of reactive gliosis, demyelination, and disseminated, perivascular infiltration by monocytic cells."' This is referred to as progressive diffuse leucoencephalopathy as it shows evidence of an intensifying, generalised degeneration of the white matter without gross inflammation.8' suggesting viral entry recently after infection. This may be confirmed by one tragic case of accidental infection with HIV-1, where virus was detected in the brain after 15 days at postmortem examination. '7 By analogy to another lentivirus, Visna, free virus could cross the blood brain barrier following replication in cells of the choroid plexus20 but a more widely held view is that HIV-1 is carried across by infected macrophages. 14 This mechanism of infection is possibly facilitated by the enhanced ability of HIV-1 infected macrophages to induce adhesion molecules on the surfaces of capillary endothelial cells of the blood brain barrier, thus allowing their binding and ultimate penetration.'4 Brain capillary endothelial cells can be infected in a non-cytolytic fashion by HIV-1 and may also contribute to CNS invasion by producing virus for the infection of normal leucocyte traffic.2' Once infected with HIV-1, macrophages produce high levels of the chemoattractant cytokines, macrophage inflammatory proteins la and 1B, which might recruit uninfected T cells and monocytes to sites within the CNS and amplify the infection.22 Despite the evidence indicating early entry into the CNS, ADC most frequently occurs late in the disease, raising the possibility that productive infection of the brain commonly occurs after a considerable time, '3 or that the CNS is reseeded, probably as the levels of circulating virus in the body increase late in the disease.'4 It can be speculated that the late appearance of the symptoms of ADC is due to a minor evolution ofviral tropism for the CNS. The tropism of HIV-1 is determined primarily by the V3 region of the envelope glycoprotein, gp 120, with all primary isolates of HIV-1 being able to infect both macrophage and activated T lymphocyte cell cultures. Two reports document CNS derived HIV-1 as possessing an altered V3 region in patients suffering from dementia.2324
Following the discovery of a close association between neurological dysfunction and HIV-1 infection, many studies were undertaken to determine which elements of the CNS became infected during ADC. Shaw '4 Once activated, HIV-1 infected macrophages produce significant amounts of the cytokines, TNFa and IL-1,B, and the bioactive metabolites, eicosanoids, quinolinic acid, platelet activating factor (PAF), and nitric oxide, which are directly or indirectly neurotoxic.' 53 56-62 The levels of most of these potential neurotoxins (TNFa, IL-1,B, quinolinic acid, PAF, eicosanoids and the inducible form of nitric oxide synthetase) are known to be elevated in the CSF or brain tissue of patients with neurological disease."4 56 63 64 Of the cytokines, TNFa mediates neuronal damage and dysfunction at several levels. It is known to upregulate HIV-1 replication and may act on infected macrophages in an autocrine manner" to increase the production of neurotoxic viral proteins, while at the same time it is cytotoxic to both oligodendrocytes and neurons by an apoptotic mechanism.60 61 At subcytotoxic doses, but in the presence of a glutamate receptor agonist, it exerts neurotoxicity by activation of the neuronal a-amino-3- 
